1. Home
  2. UPLD vs LEXX Comparison

UPLD vs LEXX Comparison

Compare UPLD & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UPLD
  • LEXX
  • Stock Information
  • Founded
  • UPLD 2010
  • LEXX 2004
  • Country
  • UPLD United States
  • LEXX Canada
  • Employees
  • UPLD N/A
  • LEXX 7
  • Industry
  • UPLD Computer Software: Prepackaged Software
  • LEXX Biotechnology: Pharmaceutical Preparations
  • Sector
  • UPLD Technology
  • LEXX Health Care
  • Exchange
  • UPLD Nasdaq
  • LEXX Nasdaq
  • Market Cap
  • UPLD 67.6M
  • LEXX 38.9M
  • IPO Year
  • UPLD 2014
  • LEXX N/A
  • Fundamental
  • Price
  • UPLD $4.33
  • LEXX $2.23
  • Analyst Decision
  • UPLD Hold
  • LEXX Strong Buy
  • Analyst Count
  • UPLD 3
  • LEXX 2
  • Target Price
  • UPLD $3.75
  • LEXX $11.00
  • AVG Volume (30 Days)
  • UPLD 713.1K
  • LEXX 202.4K
  • Earning Date
  • UPLD 02-20-2025
  • LEXX 01-10-2025
  • Dividend Yield
  • UPLD N/A
  • LEXX N/A
  • EPS Growth
  • UPLD N/A
  • LEXX N/A
  • EPS
  • UPLD N/A
  • LEXX N/A
  • Revenue
  • UPLD $278,945,000.00
  • LEXX $464,278.00
  • Revenue This Year
  • UPLD N/A
  • LEXX $20.39
  • Revenue Next Year
  • UPLD N/A
  • LEXX $113.25
  • P/E Ratio
  • UPLD N/A
  • LEXX N/A
  • Revenue Growth
  • UPLD N/A
  • LEXX 105.24
  • 52 Week Low
  • UPLD $1.79
  • LEXX $1.20
  • 52 Week High
  • UPLD $5.64
  • LEXX $6.85
  • Technical
  • Relative Strength Index (RSI)
  • UPLD 53.72
  • LEXX 47.23
  • Support Level
  • UPLD $4.03
  • LEXX $2.00
  • Resistance Level
  • UPLD $5.25
  • LEXX $2.54
  • Average True Range (ATR)
  • UPLD 0.67
  • LEXX 0.24
  • MACD
  • UPLD -0.07
  • LEXX -0.00
  • Stochastic Oscillator
  • UPLD 34.17
  • LEXX 27.06

About UPLD Upland Software Inc.

Upland Software Inc is a provider of cloud-based enterprise work management software. The company provides a family of cloud-based enterprise work management software applications for the information technology, process excellence, finance, professional services and marketing functions within organizations. It services customers ranging from corporations and Government agencies to small- and medium-sized businesses engaged in the field of financial services, retail, technology, manufacturing, education, consumer goods, media, and telecommunications, Government, food and beverage, healthcare and life sciences, chemicals and travel and hospitality. The products of the company are Altify, BA Insight, InGenius, Panviva, Qvidian, RightAnswers and others.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

Share on Social Networks: